Cargando…

Fragment-based identification of multi-target ligands by self-organizing map alignment

Detalles Bibliográficos
Autores principales:	Achenbach, Janosch, Klingler, Franca-Maria, Hahn, Steffen, Steinbrink, Svenja, Schroeder, Mirjam, Loehr, Frank, Doetsch, Volker, Steinhilber, Dieter, Proschak, Ewgenij
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341322/ http://dx.doi.org/10.1186/1758-2946-4-S1-P57

Ejemplares similares

Design of dual ligands using excessive pharmacophore query alignment
por: Moser, Daniel, et al.
Publicado: (2012)

Systematic Assessment of Fragment Identification for Multitarget Drug Design
por: Brunst, Steffen, et al.
Publicado: (2021)

Heterodimer formation with retinoic acid receptor RXRα modulates coactivator recruitment by peroxisome proliferator-activated receptor PPARγ
por: Kilu, Whitney, et al.
Publicado: (2021)

Development and in vitro Profiling of Dual FXR/LTA4H Modulators
por: Schierle, Simone, et al.
Publicado: (2021)

NSAIDs Ibuprofen, Indometacin, and Diclofenac do not interact with Farnesoid X Receptor
por: Schmidt, Jurema, et al.
Publicado: (2015)

PocketPicker: analysis of ligand binding-sites with shape descriptors
por: Weisel, Martin, et al.
Publicado: (2007)

Rational, computer-aided design of multi-target ligands
por: Achenbach, J, et al.
Publicado: (2011)

In silico polypharmacology: retrospective recognition vs. rational design
por: Proschak, Ewgenij
Publicado: (2014)

Design and Synthesis of Arylpiperazine Serotonergic/Dopaminergic Ligands with Neuroprotective Properties
por: Mastromarino, Margherita, et al.
Publicado: (2022)

Design, Synthesis and Cellular Characterization of a Dual Inhibitor of 5-Lipoxygenase and Soluble Epoxide Hydrolase
por: Meirer, Karin, et al.
Publicado: (2016)

SBE13, a newly identified inhibitor of inactive polo-like kinase 1
por: Keppner, Sarah, et al.
Publicado: (2010)

Multi-Target Approaches in Metabolic Syndrome
por: Lillich, Felix F., et al.
Publicado: (2021)

5-Lipoxygenase: Underappreciated Role of a Pro-Inflammatory Enzyme in Tumorigenesis
por: Steinhilber, Dieter, et al.
Publicado: (2010)

Kernel learning for ligand-based virtual screening: discovery of a new PPARγ agonist
por: Rupp, Matthias, et al.
Publicado: (2010)

A Diverse Benchmark Based on 3D Matched Molecular Pairs for Validating Scoring Functions
por: Kalinowsky, Lena, et al.
Publicado: (2018)

Integrating Siderophore Substructures in Thiol-Based Metallo-β-Lactamase Inhibitors
por: Rotter, Marco J., et al.
Publicado: (2023)

Scaffold Hopping from Amodiaquine to Novel Nurr1 Agonist Chemotypes via Microscale Analogue Libraries
por: Willems, Sabine, et al.
Publicado: (2022)

The endocannabinoid anandamide has an anti-inflammatory effect on CCL2 expression in vascular smooth muscle cells
por: Pflüger-Müller, Beatrice, et al.
Publicado: (2020)

Activity Screening of Fatty Acid Mimetic Drugs Identified Nuclear Receptor Agonists
por: Helmstädter, Moritz, et al.
Publicado: (2022)

Phenolate‐Induced N−O Bond Formation versus TiemannType Rearrangement for the Synthesis of 3‐Aminobenzisoxazoles and 2‐Aminobenzoxazoles
por: Hufnagel, Benedikt, et al.
Publicado: (2022)

Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ
por: Göbel, Tamara, et al.
Publicado: (2019)

Rh(II)‐Catalyzed De‐symmetrization of Ethane‐1,2‐dithiol and Propane‐1,3‐dithiol Yields Metallo‐β‐lactamase Inhibitors
por: Krasavin, Mikhail, et al.
Publicado: (2021)

Reversible Small Molecule Inhibitors of MAO A and MAO B with Anilide Motifs
por: Hagenow, Jens, et al.
Publicado: (2020)

Fast alignment of fragmentation trees
por: Hufsky, Franziska, et al.
Publicado: (2012)

Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast
por: Schierle, Simone, et al.
Publicado: (2019)

Inhibitors of Human 5-Lipoxygenase Potently Interfere With Prostaglandin Transport
por: Kahnt, Astrid S., et al.
Publicado: (2022)

Urate transporter inhibitor lesinurad is a selective peroxisome proliferator-activated receptor gamma modulator (sPPARγM) in vitro
por: Heitel, Pascal, et al.
Publicado: (2018)

DOGS: Reaction-Driven de novo Design of Bioactive Compounds
por: Hartenfeller, Markus, et al.
Publicado: (2012)

A Long Fragment Aligner called ALFALFA
por: Vyverman, Michaël, et al.
Publicado: (2015)

Structural Insights into Plasticity and Discovery of Remdesivir Metabolite GS-441524 Binding in SARS-CoV-2 Macrodomain
por: Ni, Xiaomin, et al.
Publicado: (2021)

Fr-TM-align: a new protein structural alignment method based on fragment alignments and the TM-score
por: Pandit, Shashi Bhushan, et al.
Publicado: (2008)

N-Aryl mercaptoacetamides as potential multi-target inhibitors of metallo-β-lactamases (MBLs) and the virulence factor LasB from Pseudomonas aeruginosa
por: Yahiaoui, Samir, et al.
Publicado: (2021)

Fragment-based covalent ligand discovery
por: Lu, Wenchao, et al.
Publicado: (2021)

Alignment-free filtering for cfNA fusion fragments
por: Yang, Xiao, et al.
Publicado: (2019)

Allosteric modulation of the farnesoid X receptor by a small molecule
por: Gabler, Matthias, et al.
Publicado: (2018)

Ligand-binding site prediction of proteins based on known fragment–fragment interactions
por: Kasahara, Kota, et al.
Publicado: (2010)

MANORAA (Mapping Analogous Nuclei Onto Residue And Affinity) for identifying protein–ligand fragment interaction, pathways and SNPs
por: Tanramluk, Duangrudee, et al.
Publicado: (2016)

Correction: Fragment-based covalent ligand discovery
por: Lu, Wenchao, et al.
Publicado: (2021)

Editorial: Insights in Inflammation Pharmacology: 2021
por: Patrignani, Paola, et al.
Publicado: (2022)

Transient RNA–protein interactions in RNA folding
por: Doetsch, Martina, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ekmshousk43celrh07lk3fb4v9